Literature DB >> 21950741

Effects of statins on cholestasis: good, bad or indifferent?

Rahul Kuver.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21950741      PMCID： PMC3187547          DOI： 10.1111/j.1440-1746.2011.06836.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN： 0815-9319            Impact factor:   4.029


× No keyword cloud information.
  26 in total

Review 1.  Drug-induced cholestasis.

Authors:  S Chitturi; G C Farrell
Journal:  Semin Gastrointest Dis       Date:  2001-04

2.  Cholestasis associated with the use of pravastatin sodium.

Authors:  Robert G Batey; Michelle Harvey
Journal:  Med J Aust       Date:  2002-06-03       Impact factor: 7.738

3.  Acute cholestatic hepatitis after reinitiating treatment with atorvastatin.

Authors:  Ezequiel Ridruejo; Oscar G Mandó
Journal:  J Hepatol       Date:  2002-07       Impact factor: 25.083

4.  Marked improvement in cholestasis and hypercholesterolemia with simvastatin in a patient with primary biliary cirrhosis.

Authors:  T Kamisako; Y Adachi
Journal:  Am J Gastroenterol       Date:  1995-07       Impact factor: 10.864

5.  Acute cholestatic hepatitis associated with pravastatin.

Authors:  M Hartleb; G Rymarczyk; K Januszewski
Journal:  Am J Gastroenterol       Date:  1999-05       Impact factor: 10.864

Review 6.  Hepatotoxicity of commonly used drugs: nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs.

Authors:  Shivakumar Chitturi; Jacob George
Journal:  Semin Liver Dis       Date:  2002       Impact factor: 6.115

7.  Pravastatin modulates liver bile acid and cholesterol homeostasis in rats with chronic cholestasis.

Authors:  Gabriela Kolouchova; Eva Brcakova; Petra Hirsova; Ludek Sispera; Pavel Tomsik; Jolana Cermanova; Radek Hyspler; Martina Slanarova; Leos Fuksa; Halka Lotkova; Stanislav Micuda
Journal:  J Gastroenterol Hepatol       Date:  2011-10       Impact factor: 4.029

8.  Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers.

Authors:  Uwe Ritzel; Urs Leonhardt; Martina Näther; Gertrud Schäfer; Victor W Armstrong; Giuliano Ramadori
Journal:  J Hepatol       Date:  2002-04       Impact factor: 25.083

Review 9.  Cholestasis: human disease and experimental animal models.

Authors:  Emilio Alberto Rodríguez-Garay
Journal:  Ann Hepatol       Date:  2003 Oct-Dec       Impact factor: 2.400

10.  Experimental use of pravastatin in patients with primary biliary cirrhosis associated with hypercholesterolemia.

Authors:  T Kurihara; M Akimoto; K Abe; H Ishiguro; A Niimi; A Maeda; M Shigemoto; K Yamashita; I Yokoyama; Y Suzuki
Journal:  Clin Ther       Date:  1993 Sep-Oct       Impact factor: 3.393
View more
  2 in total

Review 1.  Statin-induced Liver Injury Patterns: A Clinical Review.

Authors:  Leon D Averbukh; Alla Turshudzhyan; David C Wu; George Y Wu
Journal:  J Clin Transl Hepatol       Date:  2022-01-10

2.  Fetal androgen exposure is a determinant of adult male metabolic health.

Authors:  Katarzyna J Siemienowicz; Panagiotis Filis; Sophie Shaw; Alex Douglas; Jennifer Thomas; Sally Mulroy; Forbes Howie; Paul A Fowler; W Colin Duncan; Mick T Rae
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.